MedPath

sefulness of lignocaine medicated pad for reducing pain in patients during administration of Rabies immunoglobulin (RIG)

Not Applicable
Completed
Conditions
Health Condition 1: null- Adult Patients (18 to 60 yrs) coming to the Preventive Clinic of Medical College, Thiruvananthapuram with Category III animal bites in whom Rabies Immunoglobulin is given
Registration Number
CTRI/2018/02/011803
Lead Sponsor
State Board of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult Patients (18 to 60 yrs) coming to the Preventive Clinic of Medical College, Thiruvananthapuram with Category III animal bites in whom Rabies Immunoglobulin (Equine Rabies immunoglobulin/Human Rabies Immunoglobulin) is adviced, with minimum 2 wounds on two different sites. Persons with more than 2 wounds will also be recruited and the most proximal and distal wound shall be taken for the study. One wound will be randomized to the intervention and the other to the placebo arm. Proximal wound is the wound closest to head and distal wound will be the one farthest from the head. In case of a wound on the face, proximity to an imaginary line drawn through the middle of the nose will be considered.

Exclusion Criteria

Those who are not giving consent

Known Allergic to Lignocaine

History of contact dermatitis

Those with any contraindications to lignocaine

All mucosal exposures

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath